Nuevolution A/S - Product Pipeline Review - 2014

Published: Dec, 2014 | Pages: 25 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Nuevolution A/S - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Nuevolution A/S - Product Pipeline Review - 2014', provides an overview of the Nuevolution A/S's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Nuevolution A/S's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Nuevolution A/S including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Nuevolution A/S's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Nuevolution A/S's pipeline products

Reasons to buy

- Evaluate Nuevolution A/S's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Nuevolution A/S in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Nuevolution A/S's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Nuevolution A/S and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Nuevolution A/S
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Nuevolution A/S and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Nuevolution A/S Snapshot 4
Nuevolution A/S Overview 4
Key Information 4
Key Facts 4
Nuevolution A/S - Research and Development Overview 5
Key Therapeutic Areas 5
Nuevolution A/S - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Pipeline Products - Partnered Products 9
Partnered Products/Combination Treatment Modalities 10
Pipeline Products - Out-Licensed Products 11
Out-Licensed Products/Combination Treatment Modalities 12
Nuevolution A/S - Pipeline Products Glance 13
Nuevolution A/S - Early Stage Pipeline Products 13
Discovery Products/Combination Treatment Modalities 13
Nuevolution A/S - Drug Profiles 14
Small Molecules for Cancer 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Small Molecules for Inflammation 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Small Molecules for Undisclosed Indication 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Small Molecules to Modulate GPCR for Undisclosed Indication 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Nuevolution A/S - Pipeline Analysis 18
Nuevolution A/S - Pipeline Products by Target 18
Nuevolution A/S - Pipeline Products by Molecule Type 19
Nuevolution A/S - Pipeline Products by Mechanism of Action 20
Nuevolution A/S - Recent Pipeline Updates 21
Nuevolution A/S - Dormant Projects 22
Nuevolution A/S - Locations And Subsidiaries 23
Head Office 23
Appendix 24
Methodology 24
Coverage 24
Secondary Research 24
Primary Research 24
Expert Panel Validation 24
Contact Us 25
Disclaimer 25

List of Tables
Nuevolution A/S, Key Information 4
Nuevolution A/S, Key Facts 4
Nuevolution A/S - Pipeline by Indication, 2014 6
Nuevolution A/S - Pipeline by Stage of Development, 2014 7
Nuevolution A/S - Monotherapy Products in Pipeline, 2014 8
Nuevolution A/S - Partnered Products in Pipeline, 2014 9
Nuevolution A/S - Partnered Products/ Combination Treatment Modalities, 2014 10
Nuevolution A/S - Out-Licensed Products in Pipeline, 2014 11
Nuevolution A/S - Out-Licensed Products/ Combination Treatment Modalities, 2014 12
Nuevolution A/S - Discovery, 2014 13
Nuevolution A/S - Pipeline by Target, 2014 18
Nuevolution A/S - Pipeline by Molecule Type, 2014 19
Nuevolution A/S - Pipeline Products by Mechanism of Action, 2014 20
Nuevolution A/S - Recent Pipeline Updates, 2014 21
Nuevolution A/S - Dormant Developmental Projects,2014 22